Integra Holdings, a Jerusalem, Israel-based investment company focused on life science innovations originating from the Hebrew University, closed a $25m funding.
The round was led by Temasek with $15M, with participation from Arie Capital, with an initial investment of $2M, The Israeli Teachers’ and Kindergarten’s Study Funds.
The funds raised will be used to advance Integra Holdings’ existing portfolio companies and to create new companies, based on promising technologies originating from the Hebrew University of Jerusalem.
Founded in 2012 by Yissum, the Technology Transfer Company of the Hebrew University and led by Dr. Liana Patt, CEO, Integra Holdings is a venture organization that aims to bring the Hebrew University’s Life Science Academic Excellence to market by taking a hands-on approach by providing its portfolio companies with the strategic planning, business development and research and development guidance they need.
The firm has a balanced portfolio of investments, based on an exclusive selection of life science companies, and focused on proprietary, innovations in the fields of biotechnology, pharmaceuticals, diagnostics and medical devices.